MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B.

MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B.
复制标题

DOI:
10.3390/cancers15194811
复制
发表时间:
2023-09-30
期刊:
影响因子:
5.2
通讯作者:
Donahue, James M.
Donahue, James M.
中科院分区:
医学2区
文献类型:
--
作者:
Phatak, Pornima;Tulapurkar, Mohan E.;Burrows, Whitney M.;Donahue, James M.

文献摘要

参考文献

相似文献

在不同类型的癌症中,特定microRNA的表达可能会发生显着变化。MiR-199 a-5 p已被证明在多种恶性肿瘤中下调,并作为肿瘤抑制因子发挥作用。我们先前已经证明,与食管上皮细胞相比,miR-199 a-5 p在食管鳞状细胞癌细胞系中显著下调。MiR-199 a-5 p被预测与Jun-B mRNA直接相互作用,Jun-B mRNA是AP 1转录因子的重要组分,具有高亲和力。我们研究的目的是确定Jun-B在食管癌细胞中的表达,并研究miR-199 a-5 p和Jun-B在这些细胞中的相互作用,并表征这种相互作用的功能意义。MicroRNA(miR)-199a-5p在某些恶性肿瘤中具有肿瘤抑制作用,但其在食管癌中的作用尚不清楚。为了进一步探索其在食管癌中的作用,我们试图研究miR-199 a-5 p和Jun-B之间的相互作用,Jun-B是AP 1转录因子的重要组成部分,其mRNA中含有miR-199 a-5 p的潜在结合位点。我们发现,与食管上皮细胞相比,miR-199 a-5 p的水平在人食管癌标本和多种食管癌细胞系中均降低。与食管上皮细胞相比,在这些肿瘤标本和几种细胞系中Jun-B表达相应升高。在miR-199 a-5 p过表达后,Jun-B mRNA表达和稳定性以及蛋白质表达显著降低。通过生物素化RNA下拉测定和荧光素酶报告基因构建体证实了miR-199 a-5 p和Jun-B mRNA之间的直接相互作用。miR-199 a-5 p的强制表达或Jun-B沉默导致细胞增殖以及AP-1启动子活性的显著降低。我们的研究结果提供了证据表明,miR-199 a-5 p在食管癌细胞中通过调节细胞增殖,部分通过抑制Jun B发挥肿瘤抑制剂的作用。
The expression of specific microRNAs may be significantly altered in different kinds of cancers. MiR-199a-5p has been shown to be downregulated in multiple malignancies and function as a tumor suppressor. We have previously shown that miR-199a-5p is markedly downregulated in esophageal squamous cancer cell lines compared to esophageal epithelial cells. MiR-199a-5p is predicted to interact directly with Jun-B mRNA, an important component of the AP1 transcription factor, with high affinity. The aim of our study was to determine expression of Jun-B in esophageal cancer cells as well as to investigate the interaction between miR-199a-5p and Jun-B in these cells and to characterize the functional implications of this interaction. MicroRNA (miR)-199a-5p has been shown to function as a tumor suppressor in some malignancies but its role in esophageal cancer is poorly understood. To further explore its role in esophageal cancer, we sought to investigate the interaction between miR-199a-5p and Jun-B, an important component of the AP1 transcription factor, which contains a potential binding site for miR-199a-5p in its mRNA. We found that levels of miR-199a-5p are reduced in both human esophageal cancer specimens and in multiple esophageal cancer cell lines compared to esophageal epithelial cells. Jun-B expression is correspondingly elevated in these tumor specimens and in several cell lines compared to esophageal epithelial cells. Jun-B mRNA expression and stability, as well as protein expression, are markedly decreased following miR-199a-5p overexpression. A direct interaction between miR-199a-5p and Jun-B mRNA was confirmed by a biotinylated RNA-pull down assay and luciferase reporter constructs. Either forced expression of miR-199a-5p or Jun-B silencing led to a significant decrease in cellular proliferation as well as in AP-1 promoter activity. Our results provide evidence that miR-199a-5p functions as a tumor suppressor in esophageal cancer cells by regulating cellular proliferation, partially through repression of Jun B.
DOI: 10.3892/ol.2021.12695
发表时间: 2021-06
期刊: Oncology letters
影响因子: 2.9
作者:
Yang N;Liang Y;Zhu T;Long Y;Chen Z;Zhang X;Jiang L
通讯作者: Jiang L
DOI: 10.1038/nature20805
发表时间: 2017-01-12
期刊: Nature
影响因子: 64.8
作者:
Cancer Genome Atlas Research Network;Analysis Working Group: Asan University;BC Cancer Agency;Brigham and Women’s Hospital;Broad Institute;Brown University;Case Western Reserve University;Dana-Farber Cancer Institute;Duke University;Greater Poland Cancer Centre;Harvard Medical School;Institute for Systems Biology;KU Leuven;Mayo Clinic;Memorial Sloan Kettering Cancer Center;National Cancer Institute;Nationwide Children’s Hospital;Stanford University;University of Alabama;University of Michigan;University of North Carolina;University of Pittsburgh;University of Rochester;University of Southern California;University of Texas MD Anderson Cancer Center;University of Washington;Van Andel Research Institute;Vanderbilt University;Washington University;Genome Sequencing Center: Broad Institute;Washington University in St. Louis;Genome Characterization Centers: BC Cancer Agency;Broad Institute;Harvard Medical School;Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University;University of North Carolina;University of Southern California Epigenome Center;University of Texas MD Anderson Cancer Center;Van Andel Research Institute;Genome Data Analysis Centers: Broad Institute;Brown University:;Harvard Medical School;Institute for Systems Biology;Memorial Sloan Kettering Cancer Center;University of California Santa Cruz;University of Texas MD Anderson Cancer Center;Biospecimen Core Resource: International Genomics Consortium;Research Institute at Nationwide Children’s Hospital;Tissue Source Sites: Analytic Biologic Services;Asan Medical Center;Asterand Bioscience;Barretos Cancer Hospital;BioreclamationIVT;Botkin Municipal Clinic;Chonnam National University Medical School;Christiana Care Health System;Cureline;Duke University;Emory University;Erasmus University;Indiana University School of Medicine;Institute of Oncology of Moldova;International Genomics Consortium;Invidumed;Israelitisches Krankenhaus Hamburg;Keimyung University School of Medicine;Memorial Sloan Kettering Cancer Center;National Cancer Center Goyang;Ontario Tumour Bank;Peter MacCallum Cancer Centre;Pusan National University Medical School;Ribeirão Preto Medical School;St. Joseph’s Hospital &Medical Center;St. Petersburg Academic University;Tayside Tissue Bank;University of Dundee;University of Kansas Medical Center;University of Michigan;University of North Carolina at Chapel Hill;University of Pittsburgh School of Medicine;University of Texas MD Anderson Cancer Center;Disease Working Group: Duke University;Memorial Sloan Kettering Cancer Center;National Cancer Institute;University of Texas MD Anderson Cancer Center;Yonsei University College of Medicine;Data Coordination Center: CSRA Inc.;Project Team: National Institutes of Health
通讯作者: Project Team: National Institutes of Health
DOI: 10.1200/jco.20.03611
发表时间: 2021-09-01
影响因子: 45.3
作者:
Goodman, Karyn A.;Ou, Fang-Shu;Ilson, David H.
通讯作者: Ilson, David H.
DOI: 10.1111/1348-0421.12345
发表时间: 2016-01-01
影响因子: 2.6
作者:
Hayashi, Miwako;Deng, Lin;Hotta, Hak
通讯作者: Hotta, Hak
DOI: 10.18632/oncotarget.6752
发表时间: 2016-02-23
期刊: Oncotarget
影响因子: --
作者:
Byrnes KA;Phatak P;Mansour D;Xiao L;Zou T;Rao JN;Turner DJ;Wang JY;Donahue JM
通讯作者: Donahue JM